These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Monitoring Fecal Microbiota Transplantation Practice in a Rapidly Evolving Health and Regulatory Environment. Kelly CR; Laine LA; Wu GD Gastroenterology; 2020 Dec; 159(6):2004-2006. PubMed ID: 32841646 [No Abstract] [Full Text] [Related]
26. Fecal microbiota transplantation in children: a brief review. Hourigan SK; Oliva-Hemker M Pediatr Res; 2016 Jul; 80(1):2-6. PubMed ID: 26982451 [TBL] [Abstract][Full Text] [Related]
27. Fecal Microbiota Transplantation in Clostridium difficile Infection: Evidence and Indications. Shaukat A; Reinink AR Am Fam Physician; 2017 Mar; 95(6):351-352. PubMed ID: 28318210 [No Abstract] [Full Text] [Related]
28. Step-up fecal microbiota transplantation (FMT) strategy. Cui B; Li P; Xu L; Peng Z; Xiang J; He Z; Zhang T; Ji G; Nie Y; Wu K; Fan D; Zhang F Gut Microbes; 2016 Jul; 7(4):323-328. PubMed ID: 26939622 [TBL] [Abstract][Full Text] [Related]
30. [Chinese experts consensus on standardized methodology and clinical application of fecal microbiota transplantation]. ; ; ; Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(Z1):5-13. PubMed ID: 32594719 [TBL] [Abstract][Full Text] [Related]
31. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy. Jiang ZD; Ajami NJ; Petrosino JF; Jun G; Hanis CL; Shah M; Hochman L; Ankoma-Sey V; DuPont AW; Wong MC; Alexander A; Ke S; DuPont HL Aliment Pharmacol Ther; 2017 Apr; 45(7):899-908. PubMed ID: 28220514 [TBL] [Abstract][Full Text] [Related]
32. Development of fecal microbiota transplantation suitable for mainstream medicine. Khoruts A; Sadowsky MJ; Hamilton MJ Clin Gastroenterol Hepatol; 2015 Feb; 13(2):246-50. PubMed ID: 25460566 [TBL] [Abstract][Full Text] [Related]
33. Fecal microbiota transplantation for Clostridium difficile infection: back to the future. Borgia G; Maraolo AE; Foggia M; Buonomo AR; Gentile I Expert Opin Biol Ther; 2015 Jul; 15(7):1001-14. PubMed ID: 26063385 [TBL] [Abstract][Full Text] [Related]
35. An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive. Brumbaugh DE; De Zoeten EF; Pyo-Twist A; Fidanza S; Hughes S; Dolan SA; Child J; Dominguez SR J Pediatr; 2018 Mar; 194():123-127.e1. PubMed ID: 29198534 [TBL] [Abstract][Full Text] [Related]
37. Faecal microbiota transplant - prospects and safety. Bartnicka A; Szachta P; Gałecka M Pomeranian J Life Sci; 2015; 61(3):282-6. PubMed ID: 27344870 [TBL] [Abstract][Full Text] [Related]
38. THE POWER OF POOP: FECAL MICROBIOTA TRANSPLANTATION FOR Edmond MB Trans Am Clin Climatol Assoc; 2016; 127():71-80. PubMed ID: 28066039 [TBL] [Abstract][Full Text] [Related]
39. Does the donor matter? Donor vs patient effects in the outcome of a next-generation microbiota-based drug trial for recurrent Clostridium difficile infection. Ray A; Jones C Future Microbiol; 2016 May; 11():611-6. PubMed ID: 26986546 [TBL] [Abstract][Full Text] [Related]
40. Successful Fecal Microbiota Transplantation as an Initial Therapy for Clostridium difficile Infection on an Outpatient Basis. Tanaka T; Kato H; Fujimoto T Intern Med; 2016; 55(8):999-1000. PubMed ID: 27086820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]